Skip to main content
. 2006 Sep 14;175(3):228–234. doi: 10.1164/rccm.200601-112OC

Figure 2.

Figure 2.

Kaplan-Meier survival curves for treatment failure during treatment with LTRA + LABA or ICS + LABA in the subjects eligible for the prespecified primary analysis (n = 110). p = 0.0008 (McNemar's test) for differential prolongation of time to failure between the treatments.